Skip to main content
Equibles
DYN logo

DYN · Dyne Therapeutics, Inc.

Track DYN — free

Use DYN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DYN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.10 +0.12 (+0.46%) At close · Aug 21
Market Cap
$4.85B
Shares
186.75M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding DYN

238 fund positions
Fund Balance Value % of Fund Open
T. Rowe Price Small-Cap Stock Fund, Inc. 7,012,202 $127,131,222 1.58%
VANGUARD TOTAL STOCK MARKET INDEX FUND 4,645,637 $84,225,399 0.00%
T. Rowe Price Small-Cap Value Fund, Inc. 4,625,081 $83,852,719 0.91%
T. Rowe Price Institutional Small-Cap Stock Fund 3,809,721 $69,070,242 1.59%
State Street(R) SPDR(R) S&P(R) Biotech ETF 3,437,524 $62,322,310 0.84%
T. Rowe Price Capital Appreciation Fund 3,279,669 $59,460,399 0.09%
iShares Russell 2000 ETF 3,253,081 $58,978,359 0.08%
Fidelity Growth Company Fund 2,862,005 $55,322,557 0.06%
Janus Henderson Global Life Sciences Fund 2,528,224 $45,836,701 0.88%
Select Biotechnology Portfolio 1,883,544 $36,408,906 0.69%
VANGUARD SMALL-CAP INDEX FUND 1,706,834 $30,944,900 0.02%
VANGUARD EXTENDED MARKET INDEX FUND 1,603,230 $29,066,560 0.04%
Fidelity Small Cap Index Fund 1,317,799 $23,127,372 0.07%
VANGUARD SMALL-CAP VALUE INDEX FUND 1,086,789 $19,703,485 0.03%
JPMorgan Small Cap Growth Fund 969,186 $17,571,342 0.81%
iShares Biotechnology ETF 917,470 $16,633,731 0.20%
T. Rowe Price New Horizons Fund, Inc. 872,825 $15,824,317 0.12%
Fidelity Growth Company K6 Fund 793,272 $15,333,948 0.06%
Fidelity Series Growth Company Fund 745,000 $14,400,850 0.06%
Fidelity Extended Market Index Fund 744,640 $14,393,891 0.03%
iShares Russell 2000 Value ETF 777,573 $14,097,398 0.11%
abrdn Life Sciences Investors 763,959 $13,850,577 2.47%
Schwab U.S. Small-Cap ETF 688,953 $13,317,461 0.06%
VANGUARD RUSSELL 2000 INDEX FUND 684,647 $13,234,227 0.08%
JNL/T. Rowe Price Capital Appreciation Fund 691,258 $12,532,508 0.09%
abrdn Healthcare Investors 666,425 $12,082,285 1.06%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 582,369 $10,558,350 0.13%
Franklin Biotechnology Discovery Fund 519,232 $9,112,522 0.88%
Franklin Small Cap Growth Fund 505,324 $8,868,436 0.36%
Fidelity Advisor Biotechnology Fund 482,000 $8,459,100 0.44%
Wasatch Ultra Growth Fund 433,765 $7,864,159 1.96%
VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO 326,259 $7,246,212 0.10%
Artisan International Small-Mid Fund 398,535 $7,225,440 0.27%
Dimensional U.S. Small Cap ETF 390,218 $6,848,326 0.05%
VANGUARD HEALTH CARE INDEX FUND 345,926 $6,686,750 0.04%
iShares Russell 2000 Growth ETF 348,206 $6,312,975 0.05%
T. Rowe Price Capital Appreciation Equity ETF 347,796 $6,305,541 0.10%
Small Cap Value Portfolio 277,110 $6,154,613 0.93%
JPMorgan Small Cap Blend Fund 312,889 $5,672,678 0.40%
BlackRock Health Sciences Opportunities Portfolio 278,934 $5,391,794 0.09%
Fidelity Total Market Index Fund 271,846 $5,254,783 0.00%
Schwab Small-Cap Index Fund 292,654 $5,136,078 0.07%
Nuveen Quant Small Cap Equity Fund 283,050 $4,967,528 0.13%
ClearBridge Small Cap Growth Fund 276,016 $4,844,081 0.24%
VANGUARD EXPLORER FUND 261,062 $4,581,638 0.02%
T. Rowe Price Spectrum Moderate Growth Allocation Fund 228,103 $4,409,231 0.10%
Penn Series Flexibly Managed Fund 234,018 $4,242,746 0.09%
Fidelity Series Total Market Index Fund 218,673 $4,226,949 0.00%
U.S. MICRO CAP PORTFOLIO 234,981 $4,123,917 0.06%
Master Small Cap Index Series 206,225 $3,738,859 0.08%
Showing 1–50 of 238 positions
Key facts CIK 1818794 CUSIP 26818M108 13F (30d) 235 filings 229 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)